Drug Type Biological products |
Synonyms- |
Target |
Mechanism EGFR modulators(Epidermal growth factor receptor erbB1 modulators), MerTK inhibitors(Tyrosine-protein kinase Mer inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | DE | 10 Dec 2022 | |
Neoplasms | Preclinical | CH | 10 Dec 2022 | |
Neoplasms | Preclinical | US | Aerium Therapeutics, Inc.Startup | 10 Dec 2022 |